Public
- Public
- Network
- Groups
- Featured
- Popular
- People

FDA NEWS RELEASE FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants Share Post Email For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of age and older. It includes a monovalent (single) component that corresponds to the Omicron variant JN.1 strain of SARS-CoV-2.

Download link

FDA NEWS RELEASE FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants Share Post Email For Immediate Release: August 30, 2024 Today, the U.S. Food and Drug Administration granted emergency use authorization (EUA) for an updated version of the Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death. The updated vaccine is authorized for use in individuals 12 years of age and older. It includes a monovalent (single) component that corresponds to the Omicron variant JN.1 strain of SARS-CoV-2.
https://cdn.masto.host/medmastodoncom/media_attachments/files/113/052/616/216/415/185/original/bf1d1a546e72dd35.png

Notices where this attachment appears

Embed this notice
Dr. Lucky Tran :verified: (luckytran@med-mastodon.com)'s status on Saturday, 31-Aug-2024 05:57:33 JST Dr. Lucky Tran :verified:

The updated Novavax COVID vaccine has been approved by the FDA!
https://www.fda.gov/news-events/press-announcements/fda-authorizes-updated-novavax-covid-19-vaccine-better-protect-against-currently-circulating

In conversation about 3 months ago from med-mastodon.com permalink